Patients Sponsored PEER report: Building a bridge between patient advocacy and ... Understanding how to build a communication bridge between non-profits and industry.
Patients Zebras, not horses: combatting rare disease via education Elsevier launches open-access journal 'Rare' and short-form videos to educate on rare disease.
Patients Dr TikTok will see you now As Gen Z engages with healthcare services, Dr Tik Tok and Nurse Facebook become major players.
R&D JP Morgan 2023 – Lisa Yañez At JP Morgan Week, pharmaphorum caught up with Lisa Yañez, CEO of Aerami Therapeutics.
Patients Join the dots between providers to untether DCT potential Dots must be joined between stakeholders for DCTs to drive efficiency and patient centricity.
R&D JP Morgan 2023 - Astrocyte Pharmaceuticals pharmaphorum spoke with Astrocyte's Kevin Sheth, William Korinek, and James D. Lechleiter
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.